EGF receptor overexpression is observed in numerous cancers, including breast, lung, colon cancer, and squamous cell carcinoma [39]; therefore, an attempt was made to assess the effect of prolidase on cell metabolism in conditions of EGFR overexpression. This evidence concerns the gene PEPD and cancer.